Monoclonal antibody
Type ?
Source Human
Target platelet-derived growth factor receptor beta
Clinical data
ATC code none
CAS Number 1569263-06-4
ChemSpider none
Chemical and physical data
Formula C6472H9974N1710O2022S38
Molar mass 145.3 kg/mol

Rinucumab is a monoclonal antibody designed for the treatment of neovascular age-related macular degeneration.[1]

This drug was developed by Regeneron Pharmaceuticals, Inc.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Rinucumab, American Medical Association.
This article is issued from Wikipedia - version of the 2/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.